Every few decades a single change in how people eat rewrites the rules for an entire aisle. Low-fat did it in the 1990s. Low-carb did it in the 2000s. Plant-based did it in the late 2010s. The current shift is different in kind: it is driven not by a diet philosophy but by a class of medications. GLP-1 receptor agonists, the drugs sold under names like Ozempic, Wegovy, Mounjaro, and Zepbound, change appetite, portion tolerance, food preferences, and nutritional needs for the people taking them. Those people are now a large and growing share of the grocery-buying public, and their households eat differently too. For food, beverage, and supplement brands, this is a formulation brief, not just a marketing angle.
What Actually Changes for a GLP-1 User
To formulate for this consumer, you need to understand the experience, not just the headline. GLP-1 medications slow gastric emptying and act on appetite signaling in the brain. The practical effects that show up at the dinner table, as reported consistently by users and clinicians:
Much smaller portions
Fullness arrives fast and lasts. A full-size entrée, a standard protein bar, or a 16-ounce beverage can be more than a user wants in one sitting. Half-finished packages are common.
Protein becomes the priority
Rapid weight loss can include loss of lean muscle. Clinicians routinely advise users to prioritize protein at every eating occasion, which is difficult when total intake has dropped sharply.
Food aversions and GI sensitivity
Nausea, reflux, and constipation are common side effects, especially when starting or increasing a dose. Rich, greasy, very sweet, and heavily spiced foods are often the first things users stop wanting.
Hydration and micronutrient gaps
Eating less means drinking less and absorbing fewer vitamins and minerals from food. Users and their clinicians frequently look for ways to close the gap without adding volume.
Two more patterns matter for brands. First, most users are not on the medication forever; many cycle off, titrate down, or move to a maintenance phase, and they bring their new habits with them. Second, the effect is household-wide. When one adult in a home eats smaller, higher-protein, lower-sugar meals, the shopping basket for the whole household tends to move in the same direction.
Formulation Implications by Category
Protein density, not just protein content
The traditional protein bar delivers 20 grams of protein in a 60-gram, 250-calorie package. A GLP-1 user may only manage half of it. The metric that matters for this consumer is protein per calorie and protein per bite. That pushes formulation toward high-purity protein sources (whey isolate, milk protein isolate, pea and other plant isolates), leaner fat systems, and lower sugar, and it favors formats that deliver a meaningful dose in a small volume: shots, small-format ready-to-drink beverages, mini bars, high-protein puddings and yogurts, and fortified broths.
Protein density comes with technical trade-offs. High-isolate systems can be chalky, astringent, or prone to gelling in beverages at low pH. Flavor masking becomes harder when you remove the sugar and fat that usually cover protein off-notes. Expect more formulation iterations than a conventional protein product, and plan the timeline accordingly. See our formulation-to-launch timeline for how iteration rounds affect launch dates.
Fiber, chosen for tolerance
Constipation is one of the most common complaints among GLP-1 users, and fiber intake naturally drops when total food intake drops. That makes fiber a genuine functional need rather than a label-dressing ingredient. But not all fiber is equal for someone with a slowed, sensitive gut. Highly fermentable fibers such as inulin can cause bloating and gas at meaningful doses. Well-tolerated soluble fibers such as partially hydrolyzed guar gum, psyllium, and certain resistant dextrins tend to be better choices, and dose should be modest per serving with clear guidance to build up gradually.
Portion architecture and packaging
The single most under-appreciated lever is the size of the unit. Resealable packaging, half-size portions, multi-packs of small servings, and single-serve formats that do not leave a user feeling wasteful all fit this consumer. A 12-ounce beverage where the category standard is 16 ounces is not a compromise; it is the right size. This also has cost and margin implications, which our COGS and unit economics guide can help you model, since smaller units usually carry higher packaging cost as a share of the total.
Texture, flavor, and gentleness
Users frequently report new aversions to greasy, very sweet, or strongly flavored foods. Products that lean savory, mildly flavored, smooth-textured, and easy to digest tend to perform better. Soups, broths, smoothies, soft bars, and yogurts have an advantage over crunchy, dense, or fried formats. Lower sugar is not optional in this space; many users find intensely sweet products actively unpleasant.
Hydration and electrolytes
Reduced fluid intake plus GI side effects makes hydration a real need. Low-sugar or zero-sugar electrolyte powders and ready-to-drink hydration beverages, ideally with modest volume and gentle flavor, have found a natural audience here. Adding protein or fiber to a hydration product is possible but pushes into difficult formulation territory; keep the brief focused.
Micronutrient support
Supplement brands have an obvious role. Users eating significantly less often look for a comprehensive multivitamin, and there is specific interest in nutrients tied to muscle maintenance and general wellness during weight loss. Delivery format matters: a large tablet is unappealing to someone with a sensitive stomach, so gummies, small capsules, powders, and liquids have an edge. Our overview of functional ingredient trends covers the broader ingredient landscape.
A Product Opportunity Map
| Consumer Need | Product Formats That Fit | Formulation Watch-outs |
|---|---|---|
| Protein in a small package | Protein shots, mini RTDs, high-protein yogurt and pudding, fortified broth, mini bars | Off-notes from isolates, viscosity and gelling in RTDs, chalkiness in powders |
| Digestive comfort | Gentle soluble fiber powders, fiber-fortified beverages, probiotic formats | Fermentability and gas, dose escalation guidance, stability of probiotics |
| Hydration | Low-sugar electrolyte powders and RTDs in smaller volumes | Sodium load, flavor intensity, avoiding heavy sweetness |
| Nutrient gaps | Multivitamins in gummy, small capsule, powder, or liquid form | Pill size and count, iron tolerance, gummy stability and sugar content |
| Real meals at real sizes | Half-portion frozen entrées, soups, savory snacks in small packs | Sodium in ready meals, freezer-to-plate texture, packaging cost per unit |
| Off-ramp and maintenance | All of the above, positioned for habit continuity rather than the medication | Avoiding positioning that dates the product to a single medication cycle |
The Claims Line You Cannot Cross
This is the part of the trend that creates regulatory risk, and it deserves more caution than most brands are showing. A food or dietary supplement cannot claim to treat, mitigate, or prevent a disease, and it cannot claim to affect a drug's action or replace it. Words like "GLP-1 support," "natural Ozempic," "boosts GLP-1," or "helps your medication work" are red flags. Structure/function claims for supplements must be truthful, substantiated, and accompanied by the required disclaimer, and even a well-worded claim about "supporting healthy appetite" needs evidence behind it. The FTC has been active on weight-loss claims for years and treats implied claims, including imagery and testimonials, as seriously as explicit ones.
The safer and, in our experience, more durable positioning describes the consumer's need rather than the medication: high protein, small portion, gentle on the stomach, low sugar, easy to digest. Those are claims you can substantiate with a nutrition panel and a formulation, and they will still be true when the consumer's medication status changes. Our FDA compliance guide walks through claim substantiation in more depth.
Retailer scrutiny is rising too. Major retailers and online marketplaces have their own claim policies, and "GLP-1" in product names or on-pack copy is increasingly being flagged during listing review. Build the product for the need, and let your merchandising and content strategy speak to the audience without putting a drug name on the label.
How to Build for This Consumer Without Betting the Brand on It
- Start with your existing hero product. Can you offer a smaller size, a higher-protein version, or a lower-sugar variant? A line extension tests the demand with far less risk than a new brand.
- Write the formulation brief around metrics, not mood. Target protein per 100 calories, sugar ceiling, fiber type and dose, serving size, and pH for beverages. Vague briefs produce slow, expensive iteration.
- Test with the actual consumer early. Sensory panels of GLP-1 users, even small informal ones, will catch sweetness and texture problems that a standard panel will not.
- Plan for stability of a high-protein, low-sugar matrix. Reduced sugar and fat change water activity, texture over shelf life, and flavor drift. Start stability work at formula lock.
- Position for continuity. Many of these consumers will stay in the category long after their prescription ends. A product that is simply better for a smaller, protein-forward appetite has a longer life than one tied to a drug name.
Where CalNutri fits: High-protein, reduced-sugar, small-format products are some of the more demanding formulation and manufacturing projects in CPG. Our team has taken protein RTDs, bars, powders, and functional supplements from brief to shelf, and we can help you scope what is realistic for your brand and budget. Tell us about your product →
Building a Product for the Way People Eat Now?
Whether it's a small-format protein RTD, a gentle fiber supplement, or a right-sized ready meal, CalNutri can help you formulate, source, and manufacture it.
Start the Conversation →